Cerebral microbleeds and acute coronary syndrome: screening and progression under dual anti-platelet therapy: proof of concept study

Back

ESC Premium Access

Cerebral microbleeds and acute coronary syndrome: screening and progression under dual anti-platelet therapy: proof of concept study

Session: Bleeding complications in ACS

Topic: Pathophysiology and Mechanisms, Other

Speaker: Mr A. Alaaeldin (Dijon, FR)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Mr Abbass Alaaeldin

University Hospital Center, Dijon (France)

0 follower

4 more presentations in this session

Differential prognostic impact in mortality of myocardial infarction compared with bleeding severity in contemporary acute coronary syndrome patients

Speaker: Mr R. Cobas Paz (Vigo, ES)

Impact of prior stroke on acute myocardial infarction: population characterization and influence on in-hospital mortality and complications

Speaker: Doctor M. Carrington (Evora, PT)

Differences in the ischemic-hemorrhagic balance between diabetic and non-diabetic patients treated with dual antiplatelet theraphy with ticagrelor and prasugrel

Speaker: Mrs M. Castineira Busto (Vigo, ES)

Cardiovascular outcomes following percutaneous coronary intervention among patients with cancer: observations from a large unselected cohort

Speaker: Doctor Y. Ueki (Matsumoto, JP)

Access the full session

Bleeding complications in ACS

Speakers: Mr A. Alaaeldin, Mr R. Cobas Paz, Doctor M. Carrington, Mrs M. Castineira Busto, Doctor Y. Ueki

Access

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Cerebral microbleeds and acute coronary syndrome: screening and progression under dual anti-platelet therapy: proof of concept study

About the speaker

Mr Abbass Alaaeldin

4 more presentations in this session

Differential prognostic impact in mortality of myocardial infarction compared with bleeding severity in contemporary acute coronary syndrome patients

Impact of prior stroke on acute myocardial infarction: population characterization and influence on in-hospital mortality and complications

Differences in the ischemic-hemorrhagic balance between diabetic and non-diabetic patients treated with dual antiplatelet theraphy with ticagrelor and prasugrel

Cardiovascular outcomes following percutaneous coronary intervention among patients with cancer: observations from a large unselected cohort

Access the full session

Bleeding complications in ACS

About the event

ESC Congress 2018

ESC 365 is supported by